However, the fact that our results appear to indicate that genetically predicted reduced AMPD1 activity in CAD patients with diabetes is rather associated with increased serum concentrations of total cholesterol, LDL cholesterol, and HDL cholesterol seems to contradict the above explanation and suggests that the molecular mechanisms of this metabolic pathway are more complex. The gene discussed is AMPD1; the disease is diabetes mellitus.